首页> 外国专利> Immunoassay of human medullasin and diagnosis of multiple sclerosis using the same

Immunoassay of human medullasin and diagnosis of multiple sclerosis using the same

机译:人髓质素的免疫测定和使用该方法的多发性硬化症的诊断

摘要

There is provided an immunoassay by which the amount of human medullasin present inside granulocytes, which are one leukocyte component in blood, can be determined with high accuracy and with good reproducibility. An immunoassay of medullasin, wherein when measuring the medullasin in blood using an anti-human medullasin antibody, the determination of the amount of human medullasin in a blood sample using said anti-human medullasin antibody is carried out after treating the blood sample with an aqueous liquid having a specific osmotic pressure different to the osmotic pressure of blood to completely break up the leukocytes; and a method of diagnosing multiple sclerosis characterized in that the human medullasin content of a blood sample is measured using an immunoassay, and the onset of multiple sclerosis and the extent of the disease is diagnosed according to the size of, or changes in, this measured value. IMAGE
机译:本发明提供了一种免疫测定法,通过该测定法可以高精度且再现性良好地测定作为血液中的白细胞成分的粒细胞内存在的人髓质素的量。髓质素的免疫测定,其中当使用抗人髓质素抗体测量血液中的髓质素时,使用所述抗人髓质素抗体测定血液样品中人髓质素的量是在用水处理血液样品之后进行具有与血液的渗透压不同的比渗透压以完全破坏白细胞的液体;和诊断多发性硬化的方法,其特征在于使用免疫测定法测量血液样品中人髓质的含量,并根据所测量的大小或变化来诊断多发性硬化的发作和疾病程度值。 <图像>

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号